62 related articles for article (PubMed ID: 9219593)
41. Ipriflavone inhibits the differentiation of RAW 264.7 cells into osteoclasts via Foxo1.
Sun J; Zhang G; Hu Z
Minerva Endocrinol; 2019 Dec; 44(4):400-402. PubMed ID: 31738034
[No Abstract] [Full Text] [Related]
42. [Pharmacokinetics and metabolism of ipriflavone in humans. II].
Lévai F; Vargay Z; Bujtás G; Tóth K; Kerpel-Fronius S; Eckhardt S
Acta Pharm Hung; 1989; 59 Suppl 1():38-42. PubMed ID: 2641634
[No Abstract] [Full Text] [Related]
43. [Interaction between ipriflavone and other drugs in metabolism in vitro].
Hu XY; Yao TW
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 33(1):21-3. PubMed ID: 14966934
[TBL] [Abstract][Full Text] [Related]
44. Ipriflavone: new insights into its mechanisms of action on bone remodeling.
Brandi ML; Gennari C
Calcif Tissue Int; 1993 Feb; 52(2):151-2. PubMed ID: 8443693
[No Abstract] [Full Text] [Related]
45. [Pharmacokinetics and metabolism of ipriflavone in humans. I].
Vargay Z; Várkonyi P; Lévai F; Kerpel-Frónius S; Eckhardt S
Acta Pharm Hung; 1989; 59 Suppl 1():26-31. PubMed ID: 2701627
[No Abstract] [Full Text] [Related]
46. Ipriflavone: A New Non-Hormonal Therapeutic Agent in Osteoporosis. Satellite symposium proceedings. Florence, Italy, April 24, 1992.
Bone Miner; 1992 Oct; 19 Suppl 1():S1-64. PubMed ID: 1358372
[No Abstract] [Full Text] [Related]
47. Retraction: Ipriflavone and Ipriflavone loaded albumin nanoparticles reverse lipopolysaccharide induced neuroinflammation in rats.
PLOS ONE Editors
PLoS One; 2023; 18(11):e0294102. PubMed ID: 37917647
[No Abstract] [Full Text] [Related]
48. [The ipriflavone story].
György L; Mihály N; Marian EP; István H
Acta Pharm Hung; 1995 Nov; 65(6):191-4. PubMed ID: 8742624
[TBL] [Abstract][Full Text] [Related]
49. Glabridin, an isoflavan from licorice root, inhibits inducible nitric-oxide synthase expression and improves survival of mice in experimental model of septic shock.
Kang JS; Yoon YD; Cho IJ; Han MH; Lee CW; Park SK; Kim HM
J Pharmacol Exp Ther; 2005 Mar; 312(3):1187-94. PubMed ID: 15537821
[TBL] [Abstract][Full Text] [Related]
50. Polygonum cuspidatum, compared with baicalin and berberine, inhibits inducible nitric oxide synthase and cyclooxygenase-2 gene expressions in RAW 264.7 macrophages.
Kim KW; Ha KT; Park CS; Jin UH; Chang HW; Lee IS; Kim CH
Vascul Pharmacol; 2007; 47(2-3):99-107. PubMed ID: 17553752
[TBL] [Abstract][Full Text] [Related]
51. C2-ceramide inhibits LPS-induced nitric oxide production in RAW 264.7 macrophage cells through down-regulating the activation of Akt.
Koide N; Sugiyama T; Mori I; Mu MM; Yoshida T; Yokochi T
J Endotoxin Res; 2003; 9(2):85-90. PubMed ID: 12803880
[TBL] [Abstract][Full Text] [Related]
52. 8-Hydroxyquinoline inhibits iNOS expression and nitric oxide production by down-regulating LPS-induced activity of NF-kappaB and C/EBPbeta in Raw 264.7 cells.
Kim YH; Woo KJ; Lim JH; Kim S; Lee TJ; Jung EM; Lee JM; Park JW; Kwon TK
Biochem Biophys Res Commun; 2005 Apr; 329(2):591-7. PubMed ID: 15737626
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase by phenolic (3E)-4-(2-hydroxyphenyl)but-3-en-2-one in RAW 264.7 macrophages.
Tsao LT; Tsai PS; Lin RH; Huang LJ; Kuo SC; Wang JP
Biochem Pharmacol; 2005 Aug; 70(4):618-26. PubMed ID: 15998510
[TBL] [Abstract][Full Text] [Related]
54. Ipriflavone metabolite-III inhibits LPS-induced nitric oxide release from RAW-264.7 cells.
Koncz S; Horváth EJ
Acta Physiol Hung; 1996; 84(3):223-8. PubMed ID: 9219593
[TBL] [Abstract][Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
